Andrea B Apolo

Andrea B Apolo

UNVERIFIED PROFILE

Are you Andrea B Apolo?   Register this Author

Register author
Andrea B Apolo

Andrea B Apolo

Publications by authors named "Andrea B Apolo"

Are you Andrea B Apolo?   Register this Author

62Publications

1446Reads

17Profile Views

Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer.

Clin Genitourin Cancer 2019 Aug 27;17(4):306-314. Epub 2019 May 27.

Department of Medical Physics, University of Wisconsin, Madison, WI; University of Wisconsin Carbone Cancer Center, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.05.013DOI Listing
August 2019

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.

J Immunol 2019 Jun 29;202(12):3458-3467. Epub 2019 Apr 29.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548619PMC
June 2019

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.

J Immunother Cancer 2018 12 18;6(1):150. Epub 2018 Dec 18.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr., Rm. B2L312, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0
Publisher Site
http://dx.doi.org/10.1186/s40425-018-0473-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299503PMC
December 2018

Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma.

J Urol 2018 05 4;199(5):1129-1142. Epub 2017 Nov 4.

University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347177781
Publisher Site
http://dx.doi.org/10.1016/j.juro.2017.10.041DOI Listing
May 2018

Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.

Curr Treat Options Oncol 2018 05 28;19(7):36. Epub 2018 May 28.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive Room 12N226, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0551-zDOI Listing
May 2018

Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.

Clin Genitourin Cancer 2018 04 6;16(2):117-129. Epub 2017 Dec 6.

Bladder Cancer Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878995PMC
April 2018

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss.

Front Cell Neurosci 2017 13;11:268. Epub 2017 Sep 13.

Institute for Systems Research, University of MarylandCollege Park, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fncel.2017.00268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601400PMC
September 2017

Quantitative Assessment of Early [F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.

J Clin Oncol 2017 Aug 27;35(24):2829-2837. Epub 2017 Jun 27.

Stephanie A. Harmon, Timothy Perk, Christie Lin, Jens Eickhoff, Glenn Liu, and Robert Jeraj, University of Wisconsin-Madison; Glenn Liu and Robert Jeraj, Prostate Cancer Clinical Trials Consortium, Madison, WI; Peter L. Choyke, William L. Dahut, and Andrea B. Apolo, National Cancer Institute, Bethesda, MD; John L. Humm, Steven M. Larson, and Michael J. Morris, Memorial Sloan Kettering Cancer Center; and Steven M. Larson and Michael J. Morris, Prostate Cancer Clinical Trials Consortium, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562173PMC
August 2017

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.

J Clin Oncol 2017 Jul 4;35(19):2117-2124. Epub 2017 Apr 4.

Andrea B. Apolo and James L. Gulley, National Institutes of Health, Bethesda, MD; Jeffrey R. Infante, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Ani Balmanoukian, The Angeles Clinic & Research Institute; Alain C. Mita, Cedars Sinai Medical Center, Los Angeles; Karen Kelly, University of California-Davis, Sacramento; Marko Srdanov, Dako North America, Carpinteria, CA; Manish R. Patel, Florida Cancer Specialists & Research Institute, Sarasota, FL; Ding Wang, Henry Ford Hospital, Detroit, MI; Anthony E. Mega, The Warren Alpert Medical School at Brown University; Howard Safran, The Miriam Hospital, Providence; Howard Safran, Newport Hospital, Newport, RI; Carolyn D. Britten, Medical University of South Carolina, Charleston, SC; Alain Ravaud, CHU de Bordeaux, Bordeaux, France; Thomas E. Stinchcombe, Duke University Medical Center, Durham, NC; Arnold B. Gelb and Kevin Chin, EMD Serono, Billerica, MA; and Michael Schlichting, Merck, Darmstadt, Germany.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.6795
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.6795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493051PMC
July 2017

Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Urol Oncol 2017 07 12;35(7):473-491. Epub 2017 May 12.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931389PMC
July 2017

Immunotherapy: a new treatment paradigm in bladder cancer.

Curr Opin Oncol 2017 Mar 16. Epub 2017 Mar 16.

aGenitourinary Malignancies Branch bDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA *Nicole N. Davarpanah and Akira Yuno contributed equally to the article.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000366DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526432PMC
March 2017

Radiology Reports With Hyperlinks Improve Target Lesion Selection and Measurement Concordance in Cancer Trials.

AJR Am J Roentgenol 2017 Feb;208(2):W31-W37

1 Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 9000 Rockville Pike, Bldg 10, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.16845DOI Listing
February 2017

Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.

J Nucl Med 2016 Dec 21;57(12):1872-1879. Epub 2016 Jul 21.

Department of Medical Physics, University of Wisconsin, Madison, Wisconsin

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.177295DOI Listing
December 2016

Targeting molecular aberrations in urothelial carcinoma: are we almost there?

Am Soc Clin Oncol Educ Book 2013 :195-9

From the Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; the Translational Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EdBook_AM.2013.33.195DOI Listing
April 2016

New and promising strategies in the management of bladder cancer.

Am Soc Clin Oncol Educ Book 2015 :105-12

From the Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD; US Oncology Research, Houston, TX and Comprehensive Cancer Centers of Nevada, Las Vegas, NV; University of Colorado Cancer Center, Denver, CO.

View Article

Download full-text PDF

Source
http://meetinglibrary.asco.org/content/115000105-156
Publisher Site
http://dx.doi.org/10.14694/EdBook_AM.2015.35.105DOI Listing
February 2016

PDL1: The Illusion of an Ideal Biomarker.

Authors:
Andrea B Apolo

Eur Urol Focus 2016 Feb 6;1(3):269-271. Epub 2015 Jun 6.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.04.005DOI Listing
February 2016

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.

Bladder Cancer 2016 Jan 7;2(1):111-117. Epub 2016 Jan 7.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-150038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927849PMC
January 2016

Immunotherapies for bladder cancer: a new hope.

Curr Opin Urol 2015 Nov;25(6):586-96

aGenitourinary Malignancies Branch bDevelopmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA cDepartment of Urology, Medical University of Vienna, Vienna, Austria dCancer Research Unit, Warwick University Medical School, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000213DOI Listing
November 2015

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma.

Clin Genitourin Cancer 2015 Oct 5;13(5):410-20. Epub 2015 Mar 5.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561017PMC
October 2015

Viable tumor volume: Volume of interest within segmented metastatic lesions, a pilot study of proposed computed tomography response criteria for urothelial cancer.

Eur J Radiol 2015 Sep 10;84(9):1708-14. Epub 2015 Jun 10.

Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2015.05.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545379PMC
September 2015

A precision, personalized approach to the management of bladder cancer.

Curr Opin Urol 2015 Sep;25(5):416-7

aGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA bDepartment of Urology Caritas St. Josef Medical Centre University of Regensburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000195DOI Listing
September 2015

Imaging muscle-invasive and metastatic urothelial carcinoma.

Curr Opin Urol 2015 Sep;25(5):441-8

aRadiology and Imaging Sciences, Clinical Center, National Institutes of Health bGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000208DOI Listing
September 2015

Emerging immunotherapies for bladder cancer.

Curr Opin Oncol 2015 May;27(3):191-200

aProstate and Urologic Cancers Program, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut bDevelopmental Therapeutics Branch cGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2015/05000/Emerging
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000177DOI Listing
May 2015

Trimodality therapy in bladder cancer: who, what, and when?

Urol Clin North Am 2015 May;42(2):169-80, vii

Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, 10 CRC, B2-3500, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00940143150000
Publisher Site
http://dx.doi.org/10.1016/j.ucl.2015.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465095PMC
May 2015

Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.

JAMA Dermatol 2015 Feb;151(2):170-7

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland4section editor, JAMA Dermatology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2014.2734DOI Listing
February 2015

New facial papules in a 66-year-old woman with bladder cancer.

J Am Acad Dermatol 2014 Dec 7;71(6):1250-5. Epub 2014 Aug 7.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.07.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253599PMC
December 2014

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.

J Clin Oncol 2014 Dec 10;32(36):4172-3. Epub 2014 Nov 10.

National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.5299DOI Listing
December 2014

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder.

Cancers (Basel) 2014 Nov 25;6(4):2313-29. Epub 2014 Nov 25.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers6042313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276968PMC
November 2014

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.

Authors:
Yi-Ping Fu Indu Kohaar Lee E Moore Petra Lenz Jonine D Figueroa Wei Tang Patricia Porter-Gill Nilanjan Chatterjee Alexandra Scott-Johnson Montserrat Garcia-Closas Brian Muchmore Dalsu Baris Ashley Paquin Kris Ylaya Molly Schwenn Andrea B Apolo Margaret R Karagas McAnthony Tarway Alison Johnson Adam Mumy Alan Schned Liliana Guedez Michael A Jones Masatoshi Kida G M Monawar Hosain Nuria Malats Manolis Kogevinas Adonina Tardon Consol Serra Alfredo Carrato Reina Garcia-Closas Josep Lloreta Xifeng Wu Mark Purdue Gerald L Andriole Robert L Grubb Amanda Black Maria T Landi Neil E Caporaso Paolo Vineis Afshan Siddiq H Bas Bueno-de-Mesquita Dimitrios Trichopoulos Börje Ljungberg Gianluca Severi Elisabete Weiderpass Vittorio Krogh Miren Dorronsoro Ruth C Travis Anne Tjønneland Paul Brennan Jenny Chang-Claude Elio Riboli Jennifer Prescott Constance Chen Immaculata De Vivo Edward Govannucci David Hunter Peter Kraft Sara Lindstrom Susan M Gapstur Eric J Jacobs W Ryan Diver Demetrius Albanes Stephanie J Weinstein Jarmo Virtamo Charles Kooperberg Chancellor Hohensee Rebecca J Rodabough Victoria K Cortessis David V Conti Manuela Gago-Dominguez Mariana C Stern Malcolm C Pike David Van Den Berg Jian-Min Yuan Christopher A Haiman Olivier Cussenot Geraldine Cancel-Tassin Morgan Roupret Eva Comperat Stefano Porru Angela Carta Sofia Pavanello Cecilia Arici Giuseppe Mastrangelo H Barton Grossman Zhaoming Wang Xiang Deng Charles C Chung Amy Hutchinson Laurie Burdette William Wheeler Joseph Fraumeni Stephen J Chanock Stephen M Hewitt Debra T Silverman Nathaniel Rothman Ludmila Prokunina-Olsson

Cancer Res 2014 Oct;74(20):5808-18

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-1531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203382PMC
October 2014

Cabozantinib-induced thyroid dysfunction: a review of two ongoing trials for metastatic bladder cancer and sarcoma.

Thyroid 2014 Aug 5;24(8):1223-31. Epub 2014 Jun 5.

1 National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes, Endocrine, and Obesity Branch, National Institutes of Health , Bethesda, Maryland.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/thy.2013.0621
Publisher Site
http://dx.doi.org/10.1089/thy.2013.0621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106376PMC
August 2014

Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.

J Clin Oncol 2014 Jun 12;32(18):1868-70. Epub 2014 May 12.

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.4055DOI Listing
June 2014

Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression.

J Am Acad Dermatol 2014 Jun;70(6):1130-4

DNA Repair Section, Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01909622130129
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2013.11.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024165PMC
June 2014

Targeted therapies in urothelial carcinoma.

Curr Opin Oncol 2014 May;26(3):305-20

aGenitourinary Malignancies Branch bUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000064DOI Listing
May 2014

Consistency and efficiency of CT analysis of metastatic disease: semiautomated lesion management application within a PACS.

AJR Am J Roentgenol 2013 Sep;201(3):618-25

Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr, Bldg 10, Rm 1C340 Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.12.10136
Publisher Site
http://dx.doi.org/10.2214/AJR.12.10136DOI Listing
September 2013

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

J Natl Cancer Inst 2013 Apr 14;105(7):499-503. Epub 2013 Feb 14.

Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691944PMC
April 2013

Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer.

J Natl Cancer Inst 2013 Jan 23;105(1):69-73. Epub 2012 Dec 23.

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 8717 Grovemont Cir, Bethesda, MD 20892-4605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djs458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536639PMC
January 2013

The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.

J Nucl Med 2012 Aug 22;53(8):1175-84. Epub 2012 Jun 22.

Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.100883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474293PMC
August 2012

Clinical states model for biomarkers in bladder cancer.

Future Oncol 2009 Sep;5(7):977-92

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.09.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705955PMC
September 2009

Novel tracers and their development for the imaging of metastatic prostate cancer.

J Nucl Med 2008 Dec 7;49(12):2031-41. Epub 2008 Nov 7.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.108.050658
Publisher Site
http://dx.doi.org/10.2967/jnumed.108.050658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310891PMC
December 2008